NCT03672019 - A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Malignant Biliary Obstruction

Interventions

BEHAVIORAL

FACT-Hep

Patient Reported Outcomes (PRO) assessments at baseline and at three time points post-procedure: 4 weeks (+/- 1 weeks), 12 weeks (+/- 2 weeks), and 6 months (+/- 2 weeks).

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (Consent only), Harrison

11725

Memorial Sloan Kettering Commack (Consent only), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent only), Middletown

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER